Plain-English translation of NCT06705764 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing a medication called to help adults with severe asthma who have frequent emergency room visits. The study will compare this new medication against a placebo (a dummy injection with no active ingredient) to see if it can prevent future asthma attacks. After the first phase of the study, all participants will receive the active medication to continue monitoring its effects.
Even when people with severe asthma use strong inhaler medications, many still end up in the emergency room with serious asthma attacks. Researchers believe this new medication might work differently than current treatments and could help prevent these dangerous flare-ups.
You likely qualify if…
You likely don't qualify if…
You would receive an injection under the skin every 4 weeks for 90 days—either the new medication or a placebo, decided by random assignment. The study team will track whether you return to the emergency room with an asthma attack over those 3 months. After day 90, all participants will switch to receiving the active medication and continue for another 90 days, with follow-up visits to check how you're doing and measure improvements in your asthma symptoms.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Canada